RT Journal Article
SR Electronic
T1 Estimating healthcare resource needs for COVID-19 patients in Nigeria
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.19.20178434
DO 10.1101/2020.08.19.20178434
A1 Ogunbameru, Adeteju
A1 Barrett MD, Kali
A1 Joda, Arinola E.
A1 Khan MD, Yasin A
A1 Pechlivanoglou, Petros
A1 Mac, Stephen
A1 Naimark MD, David
A1 Ximenes, Raphel
A1 Sander, Beate
YR 2020
UL http://medrxiv.org/content/early/2020/08/22/2020.08.19.20178434.abstract
AB Background Predicting potential healthcare resource use under different scenarios will help to prepare the healthcare system for a surge in COVID-19 patients. In this study, we aim to predict the effect of COVID-19 on hospital resources in Nigeria.Method We adopted a previously published discrete-time, individual-level, health-state transition model of symptomatic COVID-19 patients to the Nigerian healthcare system and COVID-19 epidemiology. We simulated different combined scenarios of epidemic trajectories and acute care capacity. Primary outcomes included expected cumulative number of cases, days until depletion resources, and number of deaths associated with resource constraints. Outcomes were predicted over a 60-day time horizon.Results In our best-case epidemic trajectory, which implies successful implementation of public health measures to control COVID-19 spread, the current number of ventilator resources in Nigeria (conservative resources scenario), were expended within five days, and 901 patients may die while waiting for hospital resources in conservative resource scenario. In our expanded resource scenarios, ventilated ICU beds were depleted in all three epidemic trajectories within 60 days. Acute care resources were only sufficient in the best-case and intermediate epidemic scenarios, combined with a substantial increase in healthcare resources.Conclusion Current hospital resources are inadequate to manage the COVID-19 pandemic in Nigeria. Given Nigeria’s limited resources, it is imperative to increase healthcare resources and maintain aggressive public health measures to reduce COVID-19 transmission.What is already known on this subject?While western countries seem to be recovering from the COVID-19 pandemic, there is an increasing community spread of the virus in many African countries.The limited healthcare resources available in the region may not be sufficient to cope with increasing numbers of COVID-19 cases.What this study adds?Using the COVID-19 Resource Estimator (CORE) model, we demonstrate that implementing and maintaining aggressive public health measures to keep the epidemic growth at a low rate, while simultaneously substantially increasing healthcare resources is critical to minimize the impact of COVID-19 on morbidity and mortality.The impact of COVID-19 in low resource settings will likely overwhelm health system capacity if aggressive public health measures are not implemented. To mitigate the impact of COVID-19 in these settings, it is essential to develop strategies to substantially increase health system capacities, including hospital resources, personal protective equipment and trained healthcare personnel and to implement and maintain aggressive public health measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKali Barrett has received personal fees from Xenios AG, outside of the submitted work; BS has received research grants and honorariums as by a Canada Research Chair in Economics of Infectious Diseases (CRC-950-232429)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study does not contain inidividual data and it is exempted from ethic approvalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesStudy data derived from primary literature are publicly available to other researchers. Other data derived from health agencies are available on request directed to these agencies.